Metallo-ß-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Boyd, Sara E; Livermore, David M; Hooper, David C; Hope, William W

Boyd, Sara E; Livermore, David M; Hooper, David C; Hope, William W.

Afiliación

Boyd SE; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom s.e.boyd@liverpool.ac.uk.
Livermore DM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom.
Hooper DC; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Hope WW; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Antimicrob Agents Chemother ; 64(10)2020 09 21.

Article en En | MEDLINE | ID: mdl-32690645

Asunto(s)

Antibacterianos; beta-Lactamasas; Antibacterianos/uso terapéutico; Asia; Bacterias Gramnegativas; Inhibidores de beta-Lactamasas/uso terapéutico; beta-Lactamasas/genética

Palabras clave

drug development; metallo-ß-lactamase; metalloenzymes; pharmacology; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Beta-Lactamasas / Antibacterianos Tipo de estudio: Screening_studies País/Región como asunto: Asia Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google